Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Voies biliaires » Néoplasie

28. Février 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Voies biliaires

Cholécystite - Cholélithiase

Écriture:

Page 1 de 857


	Articles 1 - 20 / 17129

	Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Ann Transplant Jeong IJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang WH, Yoon YI, Lee SG. PMID: 41731928 [PubMed - indexed for MEDLINE]
	Clinicopathologic characteristics, progression, and prognostic analysis of intraductal papillary neoplasm of the bile duct: a retrospective multicenter cohort study. Int J Surg Zhao ZH, Zhang R, Zhang A, Yao XX, Ma L, Shi J, Bi J, Zhang HT, Zhang R, Feng Q, Lv G, Wang M. PMID: 41731872 [PubMed - indexed for MEDLINE]
	Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial. BMJ Open Cheng Y, Xia J, Chi Y, Rao J, Cheng F, CLEAP China Liver Cancer Study Group Young Investigators (CLEAP). PMID: 41730557 [PubMed - indexed for MEDLINE]
	Comprehensive Real-World Outcomes of Multimodal Treatment in Gallbladder Cancer: A Prospective Cohort Study. J Gastrointest Cancer Vineet K, Tripathi M, Shukla PK, Vadodaria D, Joshi N, Ansari MI, Gill GS, Srivastava A, Kumar C. PMID: 41724874 [PubMed - indexed for MEDLINE]
	Machine Learning-Driven Prognostic Model Integrating Lymphocyte-to-C-Reactive Protein Ratio and TNM Staging in Gallbladder Cancer. Cancer Med Wang M, Chen Z, E F, Gu J, Bao R. PMID: 41720486 [PubMed - indexed for MEDLINE]
	Outcome of resectable distal cholangiocarcinoma in a single-centre Western patient cohort: comparison of the 7th and 8th edition of the UICC/AJCC TNM classification. Acta Oncol Holm MB, Busund S, Rihel R, Sahakyan MA, Gladhaug IP, Verbeke CS, Yaqub S, Kleive D. PMID: 41711495 [PubMed - indexed for MEDLINE]
	Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients. PLoS One Artbua P, Kentachalee N, Sitthirak S, Sa-Ngiamwibool P, Wichian P, Deenonpoe R. PMID: 41706744 [PubMed - indexed for MEDLINE]
	Twenty-year temporal trends, risk profiles, and prognostic value of clinicopathological features in gallbladder cancer following cholecystectomy. World J Gastroenterol An J, Ahn SH, Kim KH, Heo JY, Yeo MK. PMID: 41694497 [PubMed - indexed for MEDLINE]
	Gallbladder carcinoma in Brazil: Clinicopathological profile and survival outcomes from a high-volume cancer center. World J Gastroenterol Makdissi FF, Kawakami LE, Pereira MA, Kruguer JAP, Marques GF, Coelho FF, Jukemura J, Herman P. PMID: 41694496 [PubMed - indexed for MEDLINE]
	Lactate metabolism-driven tumor heterogeneity and molecular signatures in intrahepatic cholangiocarcinoma. World J Gastroenterol Wu AK, Li JY, Zhang K, Meng M, Wang X, Liu Y, Xie P, Rong WQ, Wu F, Wang HG, Meng X, Wu JX. PMID: 41694488 [PubMed - indexed for MEDLINE]
	Surgery vs. non-surgery for advanced cholangiocarcinoma post-conversion therapy with PD-1/PD-L1 inhibitors plus TKIs. Front Immunol Sun Z, Wang Y, Chen X, Yang L, Li O, Zhou J, Tan Z, Peng C. PMID: 41694340 [PubMed - indexed for MEDLINE]
	Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transpl Int Kodali S, Connor AA, Victor DW 3rd, Abdelrahim M, Elaileh A, Patel K, Brombosz EW, Graviss EA, Nguyen DT, Xu S, Moore LW, Schwartz MR, Dhingra S, Basra T, Jones-Pauley MR, Noureddin M, Mobley CM, Hobeika MJ, Simon CJ, Lee Cheah Y, Heyne K, Kaseb AO, Saharia A, Gaber AO, Ghobrial RM. PMID: 41685088 [PubMed - indexed for MEDLINE]
	Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas. Int J Mol Sci Gutmans J, Friedlaender A, Mechahougui H. PMID: 41684016 [PubMed - indexed for MEDLINE]
	Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence. Int J Mol Sci Trifylli EM, Angelakis A, Fortis SP, Kriebardis AG, Papadopoulos N, Koustas E, Sarantis P, Karamouzis MV, Manolakopoulos S, Deutsch M. PMID: 41683945 [PubMed - indexed for MEDLINE]
	Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study. J Immunother Cancer Piao M, Li C, Li S, Zhang N, Li J, Luo X, Liu R, Wang F, Shi X, Liu C, Tan G, Zhu Z, Yang X, Zhao H. PMID: 41667152 [PubMed - indexed for MEDLINE]
	How I Do It: Systemic Therapies for Primary Liver Cancers. Radiology Kim TH, Harding JJ, Chernyak V, Mendiratta-Lala M, Lee JM, Do RKG. PMID: 41665497 [PubMed - indexed for MEDLINE]
	Emergence of Liquid Biopsy in Precision Oncology: A Review of its diagnostic, Predictive and Therapeutic Applications in Gallbladder Cancer. J Gastrointest Cancer Das D, Dixit R, Pandey M. PMID: 41649626 [PubMed - indexed for MEDLINE]
	Feasibility of Radioembolization With Yttrium-90 Resin Microspheres Without Lung Shunt Fraction Measurement for Intrahepatic Cholangiocarcinoma. Korean J Radiol Lee M, Kim DH, Suh M, Paeng JC, Kim HC. PMID: 41633394 [PubMed - indexed for MEDLINE]
	Development of A Risk Assessment Model for Venous Thromboembolism among Patients with Cholangiocarcinoma. Clin Appl Thromb Hemost Niprapan P, Phinyo P, Lapisatepun W, Charoentum C, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Hantrakool S, Rattanathammethee T, Rattarittamrong E, Norasetthada L, Chai-Adisaksopha C. PMID: 41632584 [PubMed - indexed for MEDLINE]
	Prognostic impact of individual resection and dissection margins in resected perihilar cholangiocarcinoma: retrospective study. BJS Open Ten Haaft BHEA, Ahmad Al-Saffar H, Roos E, Ali M, Klümpen HJ, Nooijen L, Franken L, Kazemier G, Fernandez Moro C, Verheij J, Erdmann JI, Sturesson C. PMID: 41632543 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 17129

Page 1 de 857



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité